Our qRT-PCR assay showed that SLC16A1-AS1 overexpression significantly downregulated miR194 expression but upregulated SOCS2 expression, indicating that SLC16A1-AS1 may also suppress BC by the miR194/SOCS2 axis (Supplementary Figure 1). The gene discussed is SOCS2; the disease is breast cancer.